Who owns Corcept Therapeutics Incorporated?

Key details on Corcept Therapeutics Incorporated (Ticker: CORT)

Who owns Corcept Therapeutics Incorporated?

Is CORT a good stock to own? Find out who bought Corcept Therapeutics Incorporated, who sold Corcept Therapeutics Incorporated (CORT) stock, and who holds a large position in Corcept Therapeutics Incorporated.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 14.16M $85.10M June 30, 2015
TimesSquare Capital Management 4.10M $11.45M Sept. 30, 2012
Investor AB 3.09M $17.30M March 31, 2015
Credit Suisse AG 2.73M $7.61M Sept. 30, 2012
Vanguard 2.63M $15.82M June 30, 2015
BlackRock Institutional Trust Company, N.A. 2.48M $14.93M June 30, 2015
Jennison Associates 2.15M $9.38M March 31, 2014
MORGAN STANLEY 1.75M $10.50M June 30, 2015
BlackRock Fund Advisors 1.63M $9.82M June 30, 2015
First Eagle Investment Management 991978 $3.19M Dec. 31, 2013
STATE STREET CORPORATION 838897 $5.04M June 30, 2015
TCW 718786 $1.03M Dec. 31, 2012
NORTHERN TRUST 712624 $2.29M Dec. 31, 2013

Who sold Corcept Therapeutics Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Adage Capital Partners GP March 31, 2013 1.01M $2.03M
Franklin Resources March 31, 2011 988800 $4.20M
Maverick Capital March 31, 2008 1.38M $4.43M